Em parceria com a Gilead Sciences, Luft Logistics adota embalagens ecológicas

Solução Stable EcoBox está sendo utilizada pela Luft Healthcare para o transporte de medicamentos termolábeis voltados ao tratamento de câncer de mama SÃO PAULO, 1 de junho de 2023 /PRNewswire/ — A Luft Healthcare, operadora logística da Luft Logistics especializada na área da Saúde, acaba de adotar a linha Stable EcoBox de embalagens térmicas de … Read more

Activity to promote TCM cultural exchanges and cooperation between China and Luxembourg completes success

BEIJING, June 1, 2023 /PRNewswire/ — An activity to promote traditional Chinese medicine (TCM) cultural exchanges and cooperation between China and Luxembourg held recently at the Luxembourg Embassy in China achieved a complete success. A delegation of Zhejiang Longevity Valley Botanical Co., Ltd (603896.SH) visited the Embassy and conducted an in-depth exchange of views on … Read more

Launch of topical anaesthetic Pliaglis® in Europe

VIENNA, June 1, 2023 /PRNewswire/ — Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets including Germany, the United Kingdom (“UK”), and Ireland. Further markets including Brazil will follow by the … Read more

Biodegradable medical plastics market to grow by USD 331.03 million from 2022 to 2027: Growing geriatric population to boost the growth during the forecast period

NEW YORK, June 1, 2023 /PRNewswire/ — The global biodegradable medical plastics market as a part of the specialty chemicals market. The biodegradable medical plastics market size is estimated to grow at a CAGR of 11.9% between 2022 and 2027.  The primary factor fueling the expansion of the global biodegradable medical plastics market is consumers’ … Read more

Launch of topical anaesthetic Pliaglis® in Europe

VIENNA, June 1, 2023 /PRNewswire/ — Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets including Germany, the United Kingdom (“UK”), and Ireland. Further markets including Brazil will follow by the … Read more

WuXi Biologics to Increase Manufacturing Capacity in Germany

–  In response to global clients’ increasing demand for contract manufacturing services, WuXi Biologics is expanding its capacity for drug substance and drug product in Germany –  The investment promotes the creation of additional high-skilled jobs –  As part of WuXi Biologics’ global manufacturing network, a new drug product fill line is being installed at … Read more

ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement

This License allows abm to develop and commercialize products using CRISPR/Cas9 technology. DUBLIN and VANCOUVER, BC, June 1, 2023 /PRNewswire/ — ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Applied Biological Materials Inc (‘abm,’). This is a non-exclusive licensing agreement granting abm access to the ERS CRISPR/Cas9 patent portfolio.  ERS, co-founded by … Read more

CRScube Expands Services in Europe with New Clinical Study Collaborations

SEOUL, South Korea, June 1, 2023 /PRNewswire/ — CRScube, a leading provider of eClinical solutions, today announced its recent collaborations with two European companies. These new collaborations aim to expand the reach of CRScube’s innovative eClinical solutions in the European clinical trial industry. A Swedish biotech company headquartered in Stockholm will be utilizing several of … Read more

CRScube Expands Services in Europe with New Clinical Study Collaborations

SEOUL, South Korea, June 1, 2023 /PRNewswire/ — CRScube, a leading provider of eClinical solutions, today announced its recent collaborations with two European companies. These new collaborations aim to expand the reach of CRScube’s innovative eClinical solutions in the European clinical trial industry. A Swedish biotech company headquartered in Stockholm will be utilizing several of … Read more

Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd

Acquisition of next generation radiopharmaceutical clinical pipeline to include Auger-based systemic targeted PARP inhibitor radiation therapies Expansion of operations in the US Acquisition of commercial FDA-approved, diagnostic product NEPHROSCANTM in partnership with GE Healthcare and Ga-68 kit technology IP currently licensed to Novartis Theragnostics’ and Ariceum’s leadership teams to join forces creating a specialist team … Read more